(FN) Fabrinet - Ratings and Ratios

Exchange: NYSE • Country: Cayman Islands • Currency: USD • Type: Common Stock • ISIN: KYG3323L1005

Optical Components, Transceivers, Lasers, Sensors, Optical Cables

FN EPS (Earnings per Share)

EPS (Earnings per Share) of FN over the last years for every Quarter: "2020-03": 0.74786358705717, "2020-06": 0.74589443986053, "2020-09": 0.88411844956264, "2020-12": 0.94229181646294, "2021-03": 0.99691563189662, "2021-06": 1.1257299076335, "2021-09": 1.1961798114016, "2021-12": 1.3016350660418, "2022-03": 1.3519333920423, "2022-06": 1.5095642362044, "2022-09": 1.7578486315904, "2022-12": 1.7097647472861, "2023-03": 1.604666252129, "2023-06": 1.6546261262487, "2023-09": 1.784189029906, "2023-12": 1.8862414367204, "2024-03": 2.2106384722564, "2024-06": 2.2189801001834, "2024-09": 2.1257415952538, "2024-12": 2.3799791220263, "2025-03": 2.2377295124838, "2025-06": 2.416777519122,

FN Revenue

Revenue of FN over the last years for every Quarter: 2020-03: 411.21, 2020-06: 405.113, 2020-09: 436.639, 2020-12: 453.827, 2021-03: 479.317, 2021-06: 509.567, 2021-09: 543.322, 2021-12: 566.633, 2022-03: 564.395, 2022-06: 587.874, 2022-09: 655.429, 2022-12: 668.656, 2023-03: 665.281, 2023-06: 655.871, 2023-09: 685.477, 2023-12: 712.694, 2024-03: 731.535, 2024-06: 753.261, 2024-09: 804.228, 2024-12: 833.608, 2025-03: 871.799, 2025-06: 909.692,

Description: FN Fabrinet

Fabrinet is a leading provider of advanced optical and electro-mechanical manufacturing services, catering to a diverse range of industries including optical communication, industrial lasers, automotive, medical devices, and sensors. The companys comprehensive capabilities encompass process design, supply chain management, manufacturing, and testing, enabling the production of complex components and modules.

Key products and services offered by Fabrinet include switching products, transceivers, tunable lasers, and active optical cables, which are critical components in fiber optic networks and data centers. Additionally, the company provides lasers and sensors used in various applications, such as semiconductor processing, biotechnology, and medical devices. Fabrinets design and fabrication capabilities also extend to custom glass products, including crystals, lenses, and prisms.

From a financial perspective, Fabrinet has demonstrated a strong track record of growth, with a return on equity (ROE) of 17.83%. The companys market capitalization stands at approximately $10.66 billion, with a price-to-earnings (P/E) ratio of 33.12. To further evaluate Fabrinets performance, other key performance indicators (KPIs) such as revenue growth, gross margin, and operating margin can be analyzed. For instance, a review of the companys quarterly earnings reports reveals a consistent increase in revenue, driven by growing demand for its products and services. Furthermore, Fabrinets gross margin has remained stable, indicating effective cost management and pricing strategies.

In terms of valuation, Fabrinets current price can be assessed relative to its support and resistance levels, which are $268.6, $236.6, $202.8, and $179.2. With a current price of $310.95, the stock is trading near its 52-week high, suggesting a strong upward momentum. To determine the sustainability of this trend, further analysis of the companys fundamental data, such as its revenue growth prospects, industry trends, and competitive positioning, is necessary.

FN Stock Overview

Market Cap in USD 12,791m
Sub-Industry Electronic Manufacturing Services
IPO / Inception 2010-06-25

FN Stock Ratings

Growth Rating 79.0%
Fundamental 78.2%
Dividend Rating -
Return 12m vs S&P 500 34.7%
Analyst Rating 3.89 of 5

FN Dividends

Currently no dividends paid

FN Growth Ratios

Growth Correlation 3m 81.4%
Growth Correlation 12m 35.9%
Growth Correlation 5y 92.2%
CAGR 5y 54.30%
CAGR/Max DD 3y 1.45
CAGR/Mean DD 3y 5.71
Sharpe Ratio 12m 0.88
Alpha 45.06
Beta 0.987
Volatility 55.15%
Current Volume 566.1k
Average Volume 20d 866.7k
Stop Loss 338.6 (-5.7%)
Signal 0.00

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (332.5m TTM) > 0 and > 6% of Revenue (6% = 205.2m TTM)
FCFTA 0.07 (>2.0%) and ΔFCFTA -8.29pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 47.35% (prev 50.46%; Δ -3.11pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.12 (>3.0%) and CFO 328.4m <= Net Income 332.5m (YES >=105%, WARN >=100%)
Net Debt (-301.0m) to EBITDA (408.6m) ratio: -0.74 <= 3.0 (WARN <= 3.5)
Current Ratio 3.00 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (36.1m) change vs 12m ago -1.23% (target <= -2.0% for YES)
Gross Margin 12.09% (prev 12.35%; Δ -0.26pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 132.3% (prev 123.3%; Δ 9.00pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM)

Altman Z'' 9.68

(A) 0.57 = (Total Current Assets 2.43b - Total Current Liabilities 809.8m) / Total Assets 2.83b
(B) 0.74 = Retained Earnings (Balance) 2.09b / Total Assets 2.83b
(C) 0.14 = EBIT TTM 355.2m / Avg Total Assets 2.58b
(D) 2.48 = Book Value of Equity 2.10b / Total Liabilities 849.6m
Total Rating: 9.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 78.21

1. Piotroski 4.50pt = -0.50
2. FCF Yield 1.74% = 0.87
3. FCF Margin 6.05% = 1.51
4. Debt/Equity 0.02 = 2.50
5. Debt/Ebitda 0.10 = 2.49
6. ROIC - WACC 7.98% = 9.97
7. RoE 17.60% = 1.47
8. Rev. Trend 96.35% = 4.82
9. Rev. CAGR 12.66% = 1.58
10. EPS Trend 90.98% = 2.27
11. EPS CAGR 12.27% = 1.23

What is the price of FN shares?

As of September 16, 2025, the stock is trading at USD 359.00 with a total of 566,077 shares traded.
Over the past week, the price has changed by -3.15%, over one month by +8.85%, over three months by +38.92% and over the past year by +60.15%.

Is Fabrinet a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Fabrinet (NYSE:FN) is currently (September 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 78.21 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FN is around 459.60 USD . This means that FN is currently undervalued and has a potential upside of +28.02% (Margin of Safety).

Is FN a buy, sell or hold?

Fabrinet has received a consensus analysts rating of 3.89. Therefore, it is recommended to buy FN.
  • Strong Buy: 3
  • Buy: 2
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the FN price?

Issuer Target Up/Down from current
Wallstreet Target Price 324.6 -9.6%
Analysts Target Price 324.6 -9.6%
ValueRay Target Price 517.6 44.2%

Last update: 2025-09-15 04:36

FN Fundamental Data Overview

Market Cap USD = 12.79b (12.79b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 934.2m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 39.083
P/S = 3.7409
P/B = 6.4543
P/EG = 1.19
Beta = 1.074
Revenue TTM = 3.42b USD
EBIT TTM = 355.2m USD
EBITDA TTM = 408.6m USD
Long Term Debt = 39.8m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 1.79m USD (from shortTermDebt, last quarter)
Debt = 41.6m USD (Calculated: Short Term 1.79m + Long Term 39.8m)
Net Debt = -301.0m USD (from netDebt column, last quarter)
Enterprise Value = 11.90b USD (12.79b + Debt 41.6m - CCE 934.2m)
Interest Coverage Ratio = unknown (Ebit TTM 355.2m / Interest Expense TTM 0.0)
FCF Yield = 1.74% (FCF TTM 206.8m / Enterprise Value 11.90b)
FCF Margin = 6.05% (FCF TTM 206.8m / Revenue TTM 3.42b)
Net Margin = 9.72% (Net Income TTM 332.5m / Revenue TTM 3.42b)
Gross Margin = 12.09% ((Revenue TTM 3.42b - Cost of Revenue TTM 3.01b) / Revenue TTM)
Tobins Q-Ratio = 5.66 (Enterprise Value 11.90b / Book Value Of Equity 2.10b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 41.6m)
Taxrate = 6.38% (22.7m / 355.2m)
NOPAT = 332.5m (EBIT 355.2m * (1 - 6.38%))
Current Ratio = 3.00 (Total Current Assets 2.43b / Total Current Liabilities 809.8m)
Debt / Equity = 0.02 (Debt 41.6m / last Quarter total Stockholder Equity 1.98b)
Debt / EBITDA = 0.10 (Net Debt -301.0m / EBITDA 408.6m)
Debt / FCF = 0.20 (Debt 41.6m / FCF TTM 206.8m)
Total Stockholder Equity = 1.89b (last 4 quarters mean)
RoA = 11.74% (Net Income 332.5m, Total Assets 2.83b )
RoE = 17.60% (Net Income TTM 332.5m / Total Stockholder Equity 1.89b)
RoCE = 18.41% (Ebit 355.2m / (Equity 1.89b + L.T.Debt 39.8m))
RoIC = 17.60% (NOPAT 332.5m / Invested Capital 1.89b)
WACC = 9.62% (E(12.79b)/V(12.83b) * Re(9.65%)) + (D(41.6m)/V(12.83b) * Rd(0.0%) * (1-Tc(0.06)))
Shares Correlation 3-Years: -81.82 | Cagr: -0.17%
Discount Rate = 9.65% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 76.40% ; FCFE base≈270.0m ; Y1≈333.0m ; Y5≈568.2m
Fair Price DCF = 203.4 (DCF Value 7.27b / Shares Outstanding 35.7m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 96.35 | Revenue CAGR: 12.66%
Rev Growth-of-Growth: 8.40
EPS Correlation: 90.98 | EPS CAGR: 12.27%
EPS Growth-of-Growth: -1.49

Additional Sources for FN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle